Methods of associating genetic variants with a clinical outcome in patients suffering… Grant US-11769597-B2 United States of America 26 Sep 2023
Use of a VEGF antagonist to treat angiogenic eye disorders Grant US-11730794-B2 United States of America 22 Aug 2023
Use of a VEGF antagonist to treat angiogenic eye disorders Grant US-11707506-B2 United States of America 25 Jul 2023
Use of a VEGF antagonist to treat angiogenic eye disorders Grant US-11559564-B2 United States of America 24 Jan 2023
Methods of associating genetic variants with a clinical outcome in patients suffering… Grant US-11519020-B2 United States of America 06 Dec 2022
Methods for treating or preventing ophthalmological conditions Grant US-11273171-B2 United States of America 15 Mar 2022
Use of a VEGF antagonist to treat angiogenic eye disorders Grant US-11253572-B2 United States of America 22 Feb 2022
Use of a VEGF antagonist to treat angiogenic eye disorders Grant US-10888601-B2 United States of America 12 Jan 2021
Use of a VEGF antagonist to treat angiogenic eye disorders Grant US-10857205-B2 United States of America 08 Dec 2020
Use of a VEGF antagonist to treat angiogenic eye disorders Grant US-10828345-B2 United States of America 10 Nov 2020
Stable liquid formulation of fusion protein with IgG Fc domain Grant US-9982032-B2 United States of America 29 May 2018